Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Primary Prevention — Standard pathway
Risk category
Low
LDL-C target
<3 mmol/L
Recommended next step
Initiate high-intensity statin
No lipid-lowering therapy on file yet and no intolerance recorded — start with a high-intensity statin.
Current therapy on record
No statin · 0 month(s) on this regimen
Edit
How this was decided
- ✕ LDL-C already at target? 3.3 mmol/L vs. target <3 mmol/L.
- ✕ Currently on a statin? No statin.